Trials / Recruiting
RecruitingNCT07306104
The Effect of Long-term Daily Stimulation of the Brain With Pulsed Electromagnetic Fields on Parkinsons Disease
The Effect of Long-term Treatment of Parkinson's Disease With T-PEMF
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- University of Southern Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to learn to what extent daily stimulation of the brain with transcranial pulsed electromagnetic fields (T-PEMF) works to treat persons with Parkinson's Disease. The main questions it aims to answer are: * How does 6 months of daily treatment (30 minutes/day) with T-PEMF affects neuro-mechanical and molecular biological factors compared with placebo treatment in persons with Parkinson's disease? * How does 12 months of daily treatment (30 minutes/day) with T-PEMF affects neuro-mechanical and molecular biological factors in persons with Parkinson's disease an does 12 months of T-PEMF alters the need for medication intake? The neuro-mechanical outcomes are compared with the "natural" progression of the disease as well as with a healthy reference group. Furthermore, it will be examined whether 12 months of T-PEMF treatment alters the need for medication intake. Participants in the intervention group will: * receive one 30 min treatment session daily for 12 months * receive either T-PEMF or sham treatment for the first 6 months * receive active T-PEMF treatment the last 6 months * visit for tests before treatment initiation, after 6 months of treatment and after 12 months of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial pulsed electromagnetic fields (T-PEMF) | 30 min daily stimulation with transcranial pulsed electromagnetic fields (50 Hz) |
| DEVICE | Sham (No Treatment) | 30 min daily the participants are using/wearing the T-PEMF device but no stimulation occurs |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2028-01-01
- Completion
- 2028-01-01
- First posted
- 2025-12-29
- Last updated
- 2025-12-29
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT07306104. Inclusion in this directory is not an endorsement.